Santhera Pharmaceuticals Holding AG (SANN) — Free Cash Flow Generation Index

Latest as of December 2023: 1.00x

Santhera Pharmaceuticals Holding AG (SANN) has a Free Cash Flow Generation Index of 1.00x as of December 2023. Free cash flow of CHF62.54 Million represents 1% of operating cash flow (CHF62.63 Million). See Santhera Pharmaceuticals Holding AG working capital to net assets to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

CHF62.54 Million

CHF

Operating Cash Flow

CHF62.63 Million

CHF

Capital Expenditures

CHF90.00K

CHF

Santhera Pharmaceuticals Holding AG Free Cash Flow Generation Index (2019–2023)

Historical FCF Generation Index trend for Santhera Pharmaceuticals Holding AG across 2 annual periods. Explore Santhera Pharmaceuticals Holding AG (SANN) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Santhera Pharmaceuticals Holding AG (2019–2023)

Year-by-year Free Cash Flow Generation Index for Santhera Pharmaceuticals Holding AG. For the full company profile including market capitalisation, see SANN market cap overview.

Year	FCG Index	Free Cash Flow (CHF)	Operating CF	Capital Expenditures	YoY Change
2023	0.50x	CHF23.53 Million	CHF47.27 Million	CHF23.74 Million	▼ -45.4%
2019	0.91x	CHF2.37 Million	CHF2.60 Million	CHF229.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).